Biomere selected to exhibit at NIH Innovation Zone

Worcester, MA, May 20, 2016; Biomere is excited and honored to announce that it was one of the companies selected to exhibit its proprietary vaccination platform and lead HSV-2 (Herpes Simplex Virus Type-2) vaccine at this year’s annual BIO International Convention being held June 6-9, 2016 in San Francisco, CA.

Read more